We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The plaintiffs failed to comply with court directives to submit documentation supporting their claims and to show they used the brand name version of Abilify. Read More
Otsuka subsidiary Avanir Pharmaceuticals agreed to pay approximately $116 million to settle whistleblower fraud allegations that the company offered kickbacks to doctors and salespeople to push Nuedexta off label for dementia patients. Read More
A federal judge in Florida has thrown out 149 lawsuits in multidistrict litigation alleging Abilify (aripiprazole) caused their compulsive behavior. Read More
JHL Biotech has conceded to Genentech in a lawsuit over JHL’s development of biosimilars, to settle claims that it used stolen trade secrets to develop copycat drugs. Read More
Teva Pharmaceutical launched its generic version of Mylan’s EpiPen Jr. (epinephrine) auto-injector 0.15mg at a wholesale cost of $300 per two-pack, the drugmaker announced Tuesday. Read More
The commission believes that a lack of competition between the two rival firms could harm competition in a market that’s long been prone to price-fixing. Read More
An antitrust lawsuit filed in a federal court in New York claims AstraZenica struck a deal with generic drugmakers to hold off on launching versions of its anti-psychotic drug Seroquel XR. Read More
Allergan has agreed to pay $2.74 million to three labor union health funds in a bid to bring antitrust litigation against the drugmaker to a close. The payments, revealed in documents filed in the U.S. District Court for Massachusetts, resolves claims from certain plaintiffs that alleged anticompetitive behavior related to the ulcerative colitis drug Asacol (mesalamine). Read More